May 2014 FDA Recall Drug by Bristol-meyers Squibb
D-1595-2014 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Bristol-meyers Squibb on May 12, 2014 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1595-2014

Reason for Recall
Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials
Initiated
05-12-2014
Reported
09-24-2014
Quantity
50,724 Vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Bristol-Meyers Squibb
Nationwide, Canada
COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96

Batch or Lot Expiration Information

Lot# Lot 00201125, Exp. 09/14; 00201126 Exp.11/14; 00201127, Exp.12/14; 00201228 Exp.06/15; 00201229 Exp. 07/15; 00201230, Exp. 09/15